United Therapeutics (UTHR) Tops Q4 EPS Views

United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.68, $1.13 better than the analyst estimate of $2.55. Revenue for the quarter came in at $404.9 million versus the consensus estimate of $388.29 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Tops Q2 EPS by 62c
• Black Rock Coffee Bar, Inc. (BRCB) Misses Q2 EPS by 1c